Welcome to our dedicated page for HEALWELL AI A SUB VTG news (Ticker: HWAIF), a resource for investors and traders seeking the latest updates and insights on HEALWELL AI A SUB VTG stock.
HEALWELL AI Inc. develops and commercializes healthcare artificial intelligence software for preventative care, with a focus on clinical decision support, early disease identification, and workflow tools for healthcare providers. News about HWAIF commonly covers the company’s DARWEN™ AI platform, Smart Search, Smart Summary, Smart ID, and the use of AI-enriched clinical data to support real-world evidence across disease areas.
Company updates also include revenue and Adjusted EBITDA reporting, integration of Orion Health, enterprise health-system and Health Information Exchange software contracts, customer renewals, scientific publications, conference participation, and board or governance changes. HEALWELL trades on the Toronto Stock Exchange as AIDX and on the OTCQX market as HWAIF.
HEALWELL AI (HWAIF) reported new peer-reviewed research showing its DARWEN™ AI platform outperforming published benchmarks for leading general-purpose AI models and delivering real-world patient impact in 2026 studies.
At AMIA 2026, DARWEN™-powered SMARTSuite clinical summaries exceeded OpenAI GPT, DeepSeek and Llama benchmarks with average improvements of 43% in ROUGE-1, 21% in ROUGE-2 and 43% in ROUGE-L. Separate AI-MEDX 2026 validation showed DARWEN™ treatment-plan accuracy of 54.7% versus 37.3% for Meta-Llama-3-70B-Instruct in blinded clinician review. A Canadian Journal of Cardiology study of SMART Patient ID identified over 4,100 undertreated heart failure patients and helped drive a 70% improvement in treatment optimization within six months.
Research using DARWEN™ has been accepted across 12 fall 2026 forums and includes collaborations with AstraZeneca, Bayer, Galderma, UCB, Takeda, Arcutis and Merck.
HEALWELL AI (HWAIF) and WELL Health announced that the WELLTRUST™ consented patient network, powered by HEALWELL’s DARWEN™ AI, has surpassed 100,000 patient consents since its launch in February 2026.
WELLTRUST is a WELL-managed database of patients who have expressly agreed to be contacted about clinical trials and research studies matched to their health circumstances. Consents are captured organically in-clinic via WELLSTAR’s OceanMD platform, which presents consent during digital check-in and records it as a structured, revocable entry in the patient’s chart. DARWEN’s AI matches trial protocols against this standing, continuously refreshed clinical dataset to generate pre-screened participant lists for life sciences sponsors and CROs.
WELL and HEALWELL plan to expand EMR connectivity across WELL’s approximately 275-clinic network, roll out additional digital consent channels, scale toward about one million consented patients, and pursue international expansion, including U.S. and European market readiness.
HEALWELL (OTCQX: HWAIF, TSX: AIDX), through subsidiary Orion Health, entered a multi-million-dollar, multi-year enterprise contract with Converge Health Iowa, the statewide Health Information Exchange. HEALWELL will deploy DARWEN-powered SMART Search and SMART Summary across an HIE infrastructure that currently receives data from 115 hospitals.
The agreement is expected to generate recurring revenue that HEALWELL describes as substantial relative to the current run rate of its AI & Data Sciences unit, and serves as a cross-sell proof point into Orion Health’s global customer base of approximately 70+ potential HIE opportunities. SMART tools are designed to reduce clinician chart-review burden by rapidly surfacing relevant information from longitudinal records with document-level traceability. A February 2026 Canada Health Infoway demonstration with 50 clinicians reported high perceived time savings, usability and accuracy for SMART Summary.
HEALWELL AI (TSX:AIDX, OTCQX:HWAIF) announced that its subsidiary Pentavere, developer of the DARWEN™ AI platform, has been nominated for the 2026 International Prix Galien in the Best Startup category after winning the 2024 Prix Galien USA Award for Best Digital Health Startup.
The International Prix Galien is held every two years and gathers prior national and regional winners, with 2026 nominees including major global pharmaceutical and medical technology companies. DARWEN™ analyzes complex clinical information into structured, traceable evidence and has been applied across multiple therapeutic areas. HEALWELL has integrated DARWEN™ across its healthcare technology ecosystem, including Orion Health, to leverage shared AI intellectual property across products, diseases and geographies.
HEALWELL (OTCQX:HWAIF) reported Q2-2026 revenue from continuing operations of $33.0 million, broadly flat versus $33.2 million in Q2-2025 as prior-year one-time professional services did not recur. Gross profit was $17.9 million with a 54% margin versus 56% a year earlier, and Q2 Adjusted EBITDA was $1.1 million, down from $2.3 million.
For the first half of 2026, revenue rose 60% to $66.2 million, gross profit increased 62% to $37.4 million, and Adjusted EBITDA improved to $1.9 million from $0.1 million. Operating cash flow turned positive at $4.5 million versus a $9.9 million outflow, and IFRS net loss from continuing operations narrowed to $0.45 million. HEALWELL reported Q2 IFRS net income from continuing operations of $6.4 million versus a $4.1 million loss in Q2-2025, partly reflecting fair value changes.
The company’s indirect interest in SpaceX was valued at approximately CAD$23 million as of June 30, 2026, versus a CAD$4.6 million carrying value at March 31, 2026. HEALWELL plans to monetize this position after the lock-up to further strengthen liquidity. Subscription, Support and Maintenance revenue grew 4% year-over-year in Q2 and 76% for the first half, driven largely by the Orion Health acquisition and AI cross-sell initiatives, as the company targets an approximately 10% Adjusted EBITDA margin by year-end 2026.
HEALWELL AI (TSX:AIDX, OTCQX:HWAIF) will release its fiscal second quarter 2026 financial results for the period ended June 30, 2026 after market close on Thursday, August 6, 2026. Management will discuss the results on a conference call and simultaneous webcast on Friday, August 7, 2026 at 8:30 a.m. ET (5:30 a.m. PT), hosted by CEO James Lee, President Dr. Alexander Dobranowski and CFO Anthony Lam.
Investors can access the webcast at https://bit.ly/AIDX-Q2, or join by phone via North American toll-free (+1) 800 431 2204 or Toronto/local and international (+1) 289 514 5015, dialing in 10 minutes early and requesting the “HEALWELL AI Inc. Conference Call.” The company is a healthcare artificial intelligence business focused on preventative care and advanced clinical decision support systems.
HEALWELL AI (OTCQX:HWAIF, TSX:AIDX) reported voting results from its June 25, 2026 annual general and special meeting. Shareholders holding about 66.83% of eligible votes were represented. All resolutions passed, including fixing the board at seven, re-electing all directors, reappointing Deloitte, and re-approving the 10% rolling equity incentive plan.
HEALWELL AI (OTCQX:HWAIF) reported completion of a multi-province pilot of its DARWEN-powered SMART Summary and SMART Search AI tools across British Columbia, Ontario and New Brunswick, with results accepted for presentation at the AMIA 2026 Annual Symposium in Dallas.
The company also updated investors on its indirect SpaceX stake, estimating its value at about CAD$25 million following the SpaceX IPO, and outlined IFRS treatment of a $30 million convertible debenture maturing December 31, 2029, while stating it remains in compliance with debt covenants.
HEALWELL (OTCQX:HWAIF) reported Q1-2026 revenue from continuing operations of $33.2M, up 316% year‑over‑year, driven by the Orion Health acquisition and AI division growth. Gross profit was $19.5M (59% margin). Adjusted EBITDA was positive $0.7M; IFRS net loss was $6.8M. Cash was $21.9M as of March 31, 2026.
Business highlights included a Middle East governmental AI contract, a multi‑million dollar U.S. HIE deal, launch of WELLTRUST™, and DARWEN™ reaching 47 peer‑reviewed publications.
HEALWELL AI (TSX:AIDX | OTCQX:HWAIF) will release Fiscal Q1 2026 results for the period ended March 31, 2026, after market close on Thursday, May 7, 2026. The company will host a conference call and simultaneous webcast on Friday, May 8, 2026 at 8:30 AM ET / 5:30 AM PT.
The call will be led by James Lee (CEO), Dr. Alexander Dobranowski (President) and Anthony Lam (CFO). Webcast and dial-in details are provided for live access.